Wearable Sensor Study for Estimating Heart Pumping Function
Tests a wearable sensor to estimate heart pumping function in adults with cardiotoxicity.
Key facts
- Who runs it
- Skribe Medical
- Where
- Albany, Clearwater, Germantown, Golden, Houma, Jacksonville, Littleton, Naperville, Richmond, Rochester, and Yardley, United StatesSee the 11 sites
- Trial code
- Registry title
- Novel On-body Evaluation of Cardiac Health for Oncology
- Status
- Enrolling by invitation
- People taking part
- 1,000 people, planned
- Started
- 9 Oct 2025
- Expected to end
- Mar 2027
- Type of study
- Observational, 3 groups
- Record updated
- 5 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are having an echocardiogram anyway and are willing to give consent. It tests a wearable sensor that estimates how well the heart pumps.
- Age
- 18 Years or older
- Sex
- All sexes can join.
Main reasons for not taking part
- Documented allergy to materials that touch the skin
- Any condition that would cause inaccurate echocardiogram (TTE) measurements
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Undergoing an echocardiogram irrespective of participation in this study
- Willing and able to provide informed consent prior to any study-related activity
Who cannot take part
- Have a documented allergy to potential tissue contacting system materials
- Have any condition that would cause inaccurate TTE measurements
Where in United States
- Capital Cardiology AssociatesAlbany, United StatesEnrolling by invitation
- Clearwater Cardiovascular ConsultantsClearwater, United StatesEnrolling by invitation
- Stern Cardiovascular CenterGermantown, United StatesEnrolling by invitation
- Colorado Heart and VascularGolden, United StatesEnrolling by invitation
- Cardiovascular Institute of the SouthHouma, United StatesEnrolling by invitation
- First Coast Cardiovascular InstituteJacksonville, United StatesEnrolling by invitation
- South Denver CardiologyLittleton, United StatesEnrolling by invitation
- Midwest Cardiovascular InstituteNaperville, United StatesEnrolling by invitation
- Virginia Commonwealth UniversityRichmond, United StatesEnrolling by invitation
- Strong Memorial HospitalRochester, United StatesEnrolling by invitation
- Cardiology Consultants of PhiladelphiaYardley, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this study is to develop a wearable sensor system that can estimate left ventricular ejection fraction (LVEF), which is a measurement of the heart's function.
The 3 groups in the trial
- Healthy
No known or suspected cardiac disease
- Borderline LVEF
Known conditions that may predispose to LV dysfunction, but no prior diagnosis of reduced left ventricular ejection fraction
- Reduced LVEF
Known diagnosis of reduced left ventricular ejection fraction
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Wearable Sensor-Based Estimation of Left Ventricular Ejection Fraction (LVEF) - Pilot Study
- Plain-language title
- Wearable Sensor Study for Estimating Heart Pumping FunctionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 5 October 2026